US Stock MarketDetailed Quotes
NVNO enVVeno Medical
- 4.825
- +0.045+0.94%
Trading Apr 19 10:47 ET
64.25MMarket Cap-2526P/E (TTM)
4.855High4.760Low16.16KVolume4.750Open4.780Pre Close77.56KTurnover0.13%Turnover RatioLossP/E (Static)13.32MShares6.97052wk High1.39P/B60.59MFloat Cap2.51052wk Low--Dividend TTM12.56MShs Float141.000Historical High--Div YieldTTM1.99%Amplitude2.510Historical Low4.798Avg Price1Lot Size
About enVVeno Medical Company
enVVeno Medical Corp. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include VenoValve and enVVe. The company was founded by Norman Jaffe on December 22, 1999 and is headquartered in Irvine, CA.
Company Profile
SymbolNVNO
Company NameenVVeno Medical
Listing DateMay 31, 2018
Founded1999
CEOMr. Robert A. Berman
MarketNASDAQ
Employees31
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address70 Doppler
CityIrvine
ProvinceCalifornia
CountryUnited States of America
Zip Code92618
Phone1-949-261-2900
Websitehttp://www.hancockjaffe.com
Company Executives
- Name
- Position
- Salary
- Robert A. Berman
- Director and Chief Executive Officer
- 466.48K
- Craig Glynn
- Principal Accounting Officer, Chief Financial Officer and Treasurer
- 228.82K
- Dr. Marc H. Glickman, M.D.
- Senior Vice President and Chief Medical Officer
- 404.97K
- Robert C. Gray
- Independent Director
- 77.50K
- Dr. Sanjay Shrivastava
- Independent Director
- 75.00K
- Dr. Francis Duhay
- Independent Director
- 70.00K
- Matthew M. Jenusaitis
- Independent Director
- 75.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg